Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanin production, or melanogenesis, is the biological process by which melanin pigments are synthesized and distributed. This process is primarily responsible for pigmentation in skin, hair, and eyes, and it plays a crucial role in protecting tissues from ultraviolet (UV) radiation. It involves a complex enzymatic pathway within melanosomes inside melanocytes, regulated by factors such as UV radiation, hormones, and growth factors. The main types of melanin produced are eumelanin (brown/black) and pheomelanin (yellow/red). Proper regulation of melanin synthesis and distribution is critical for photoprotection and maintaining skin health. Disruptions in this process can lead to various pigmentation disorders and impact susceptibility to UV-induced skin damage.
Varies depending on the drug; examples include inhibiting tyrosinase activity, stimulating melanogenesis via MC1R, or inhibiting melanogenesis by blocking the MC1R signaling pathway.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanin Production.